Infectious mononucleosis in children: clinical and laboratory criteria for assessing severity
https://doi.org/10.22627/2072-8107-2022-21-2-28-33
Abstract
Рurpose: to identify clinical and laboratory criteria that mark the severity of infectious mononucleosis in children, with the identification of risk factors for the development of severe forms and unfavorable course.
Patients and methods. A comparative prospective clinical study involved 200 children aged 3 to 11 years with moderate (125 people) and severe (75 people) form of infectious mononucleosis. When comparing clinical and laboratory data in the compared groups, the Mann-Whitney test was used. For multiple comparisons, the Kruskal-Wally test was used. Significance of differences was determined at a significance level of 0.05 (p < 0.05).
Results. A comparative analysis of the clinical and laboratory manifestations of infectious mononucleosis revealed statistically significant differences in the studied parameters depending on the severity of the disease. Severe forms of infectious mononucleosis were distinguished by the most pronounced clinical symptoms, as well as changes in hematological parameters and biochemical changes. The combined etiology of infectious mononucleosis also contributed to a more severe course of the disease.
Сonclusion. Timely diagnosis and assessment of the severity of the manifest form of infectious mononucleosis determine the adequacy of the appointment of rational antiviral and pathogenetic therapy, preventing the development of adverse effects and complications.
About the Authors
L. A. Ikkes
Krasnoyarsk State Medical University named after Professor VF. Voino-Yasenetsky of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
G. P. Martynova
Krasnoyarsk State Medical University named after Professor VF. Voino-Yasenetsky of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
MD
References
1. Goncharova E.V., Senyuta N.B., Smirnova K.V., Shcherbak L.N., Gurtsevich V.E. Epstein-Barr virus (EBV) in Russia: infection of the population and analysis of LMP1 gene variants in patients with EBV-associated pathologies and in healthy individuals. Voprosy Virusologii=Questions of Virology. 2015; 60(2):11—17. (In Russ.)
2. Rybalkina T.N., Karazhas N.V., Savinkov P.A., Boshyan R.E., Lysenkova M.Y., Kornienko M.N., Veselovsky P.A., Burmistrov E.M., Lebedeva T.M., Markin P.A. Significance of herpesviruses in the etiology of a number of infectious and somatic diseases in children. Detskie Infektsii=Children's Infections. 2017; 16(3):10—19. (In Russ.) https://doi.org/10.22627/2072-8107-2017-16-3-10-19
3. Sobchak D.M., Volsky N.E., Svintsova T.A. [et al.] Human immune system and features of the pathogenesis of herpetic infection. STM. 2014; 6(3):118—127. (In Russ.)
4. Khokhlova Z.A., Popova O.A., Chuikova K.I., Yakimov V.L., Minakova Yu.V., Petrova E.I. Infectious mononucleosis in children: features of the course of the disease depending on the types of antiviral therapy. Zhurnal Infektologii=Journal of Infectology. 2017; 9(3):67—73. (In Russ.) https://doi.org/10.22625/2072-6732-2017-9-3-67-74
5. Goswami R., Shair K. H., Gershburg E. Molecular diversity of IgG responses to Epstein-Barr virus proteins in asymptomatic EpsteinBarr virus carriers. The Journal of General Virology. 2017; 998(9): 2343—2350.
6. Kharlamova F.S., N.Yu. Egorova, O.V. Shamsheva, V.F. Uchaikin, O.V. Molochkova, E.V. Novosad, T.M. Lebedeva, E.V. Simonov. The role of herpes virus infection types IV, V and VI in infectious and somatic pathology in children. Pediatriya=Pediatrics. 2017; 96(4):42—47. (In Russ.) DOI: 10.24110/0031-403X-2017-96-4-42-47
7. Clinical recommendations (treatment protocol) for the provision of medical care to children with infectious mononucleosis. FSBU National Research Institute of Children's Infections FMBA of Russia, 2013:70. (In Russ.)
8. Pat. 2172956 RF, МPК G01N 33/53, G01N 33/536, G01N 33/48. Method for diagnosis of severe forms of infectious mononucleosis caused by the Epstein-Barr virus in children. Aksenov O.A., Bukina A.A., Rodionova O.V. Research Institute of Children's Infections. №2000101936; announced 26.01.2000; published 27.08.2001. 7р. (In Russ.)
9. Pospelova N.S., Postanogova N.O., Satyukova M.O., Deryusheva A. Yu., Permyakova A.V. On the criteria for the severity of infectious mononucleosis in hospitalized children. Detskie Infektsii=Children's Infections. 2020; 19(1):26—28 (In Russ.) doi 10.22627/2072-8107-2020-19-1-26-28
10. Andreeva A.A., Ikkes L.A. Clinical and hematological characteristics of infectious mononucleosis caused by the Epstein-Barr virus in children of the first year of life. Sibirskoye Мeditsinskoye Оbozreniye=Siberian Medical Review. 2016; 100(1):91—99. (In Russ.)
11. Timchenko V.N. Diseases of civilization (measles, EBV mononucleosis) in pediatric practice: A guide for doctors. St. Petersburg: Spets-Lit, 2017:527. (In Russ.)
12. Kurtasova L.M., Shakina N.A., Ikkes L.A. Changes in the sensitivity of peripheral blood leukocytes to interferon -α2 in vitro in children with infectious mononucleosis caused by the Epstein-Barr virus in the dynamics of the disease. Infektsiya i Immunitet=Infection and Immunity. 2017; 7(1):85—90. (In Russ.) https://doi.org/10.15789/2220-7619-2017-1-85-90
13. Kikuchi K, Inoue H, Miyazaki Y, Ide F, Kojima M, Kusama K. Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity. The Japanese Dental Science Review. 2017; 53(3):95—109.
Review
For citations:
Ikkes L.A., Martynova G.P. Infectious mononucleosis in children: clinical and laboratory criteria for assessing severity. CHILDREN INFECTIONS. 2022;21(2):28-33. (In Russ.) https://doi.org/10.22627/2072-8107-2022-21-2-28-33
Views:
740
Email this article 